Safety and Effectiveness of Propagermanium in Diabetic Kidney Disease Participants Receiving Irbesartan

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

November 6, 2018

Primary Completion Date

July 23, 2020

Study Completion Date

August 18, 2020

Conditions
Diabetic Kidney Disease
Interventions
DRUG

Propagermanium

Immediate release capsule

DRUG

Placebo

Placebo capsule

Trial Locations (13)

2065

Royal North Shore Hospital, St Leonards

2145

Westmead Hospital, Westmead

2170

Liverpool Hospital, Liverpool

3021

Sunshine Hospital, Melbourne

3084

Austin Hospital, Heidelberg

3121

Epworth Hospital, Richmond

3128

Boxhill Hospital, Box Hill

4102

Princess Alexandra Hospital, Woolloongabba

4575

Sunshine Coast University Hospital, Birtinya

Unknown

Renal Research, Gosford

Melbourne Renal Research Group, Melbourne

Royal Melbourne Hospital, Melbourne

St Vincents Hospital, Melbourne

Sponsors
All Listed Sponsors
collaborator

Iqvia Pty Ltd

INDUSTRY

lead

Dimerix Bioscience Pty Ltd

INDUSTRY